Navigation Links
Chronic Pain Patients Now Have Hope With Carryover Pain Relief Provided By Repeated Interferential Treatments
Date:2/16/2009

The Infrex Plus is now providing chronic pain patients the ability to self treat at home or work on an as needed basis. The surprising development is the amount of "carryover pain relief" most patients are achieving. Now interferential treatments are extending the residual pain relief period and reducing the overall pain levels for chronic pain patients offering better treatment options without the use of opioid drugs.

(PRWEB) February 16, 2009 -- The Infrex Plus is now providing chronic pain patients the ability to self treat at home or work on an as needed basis. The surprising development is the amount of "carryover pain relief" most patients are achieving.

Carryover pain relief, often referred to as "residual pain relief", is nothing more than the time period after the interferential treatment in which the patient has no pain. The phenomenon is not new to interferential for chronic pain patients, but to be able to self-treat as needed is opening new options for the chronic pain patient. " Interferential has been the leading clinical electrotherapy form of pain relief treatment since it's onset in 1951 primarily due to carryover pain relief", but only since November 2008 has the option been affordable and available to the chronic pain patient.

Historically interferential was only available to patients in a clinical setting. The patient would schedule an appointment and then come to the clinic or hospital for the 30 minute interferential treatment. The pain relief was immediate and the patient would leave the facility scheduling a return visit in anticipation of the return of the pain. The patient and clinician guessed how long it would be before the pain returned and the severity of the pain reached the point of needing treatment. In other words the "carryover pain period" was guessed at.

Today with the Infrex Plus the patient can treat as often as necessary whenever the pain returns. The carryover pain relief period is constantly extending from treatment to treatment. This is advancing the treatment of many historically chronic conditions such as:

·   Chronic Back Pain
·   Sciatica
·   Herniated Disc
·   Bulging Disc
·   Spinal Stenosis
·   Lumbar Pain
·   Osteoarthritis
·   Fibromyalgia Syndrome
·   Shingles
·   Phantom Limb Pain
·   Restless Leg Syndrome ( RLS)
·   Cervical Spondylosis
·   Trigeminal Neuralgia
·   Reflex Sympathetic Dystrophy ( RSD)
·   Carpal Tunnel Syndrome ( CTS)

The new interferential/tens Infrex Plus is also reducing the dependency and costs of traditional opioid drugs providing the patient better, safer, and less expensive options.

###

Read the full story at http://www.prweb.com/releases/2009/02/prweb2039394.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. New research shows how chronic stress worsens neurodegenerative disease course
2. Katie Lee Joel to Conduct Cooking Demonstration for Local Patients With Chronic Kidney Disease
3. Study identifies key player in the bodys immune response to chronic stress
4. Preparation for Natural Disasters Critical for People With Diabetes, Chronic Medical Conditions
5. Patient Advocate Foundation Launches Program to Help Uninsured Virginians with Chronic, Debilitating and Life-Threatening Illness Access Quality Healthcare
6. The Leukemia & Lymphoma Society Hosts Workshop On Weighing Treatment Options For Chronic Myelogenous Leukemia
7. Link Between Chronic Pain and Insomnia Uncovered at PAINWeek 2007
8. Methadone and systematic follow-up: the best solution for managing chronic pain
9. NASN Joins Partnership to Fight Chronic Disease
10. Stomach Virus a Culprit in Chronic Fatigue Syndrome
11. Chronic fatigue syndrome linked to stomach virus
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Chronic Pain Patients Now Have Hope With Carryover Pain Relief Provided By Repeated Interferential Treatments 
(Date:3/27/2017)... , ... March 27, 2017 , ... ... Conventional sodium testing methods are complicated and require expert user knowledge. In a ... analytical method dedicated to the simplified, yet highly accurate, determination of sodium. , ...
(Date:3/27/2017)... ... March 27, 2017 , ... Golden Triangle ... 8:00am-10:00am on Monday, April 3rd to commemorate the two-year anniversary of the facility. ... area-residents to celebrate two great years while also familiarizing themselves with the facility. ...
(Date:3/27/2017)... (PRWEB) , ... March 27, 2017 , ... Harris Communications, ... of hearing, is bringing its latest products to the Deaf Seniors of America Conference, ... have the opportunity to meet with knowledgeable ASL friendly staff from Harris Communications and ...
(Date:3/25/2017)... ... ... at Swissray is pleased to announce the release of the ELITE DXA, a new ... active scan window, which is more than double that of existing bone densitometers. Historically, ... undergo an accurate total body bone density or body composition study. The ELITE ...
(Date:3/24/2017)... , ... March 24, 2017 , ... ... which will spark a conversation on the current obstacles facing infection prevention and ... completely preventable deaths caused by these infections. , The print component of ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... Israel , March 27, 2017 ... oncology and immunology, announced today that AGI-134, an immunotherapy for ... acquisition of Agalimmune Ltd., will be featured at the upcoming ... in Washington, DC to be held ... ...
(Date:3/27/2017)... 2017  BERG, a biopharmaceutical company uncovering ... approach, today announced that the company,s Interrogative ... new data using a cold-induced model to ... Joslin Diabetes Center led the investigation with ... analysis of samples.  The findings were published ...
(Date:3/27/2017)... BOSTON , March 27, 2017 ... pharmaceutical company and Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), ... commercialization of innovative therapies based upon tetracycline chemistry, ... sarecycline for the treatment of moderate to severe ... Sarecycline is a once-daily, oral, narrow spectrum tetracycline-derived ...
Breaking Medicine Technology: